Pillar Biosciences Receives CMS Coverage For FDA Approved OncoReveal® CDx Pan-Cancer Solid Tumor IVD Kit - Medical Device News Magazine

Pillar Biosciences Receives CMS Coverage For FDA Approved OncoReveal® CDx Pan-Cancer Solid Tumor IVD Kit - Medical Device News Magazine

oncoReveal® CDx is a NGS based IVD kit that uses Pillar's proprietary SLIMamp (Stem-Loop Inhibition-Mediated amplification) technology for detection of single nucleotide variants (SNVs), insertions and deletions in 22 genes using DNA isolated from formalin-fixed paraffin-embedded (FFPE) tumor tissue specimens.